Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: Market Shares of Regional Market Segments of the In Vitro Toxicity Testing Markets, 2018 (North America, Europe, Asia Pacific, ROW)
Figure 1-2: Market Size and Growth Trends of Various Toxicity Endpoint Segments of the Global In Vitro Toxicity Testing Markets (2018-2023) ($ Million) (ADME-Tox; Cytotoxicity; Genotoxicity; Ocular Toxicity; Skin Irritation, Corrosion, and Sensitization; Dermal Toxicity; Carcinogenicity; Phototoxicity; Neurotoxicity; Organ Toxicity; Other Endpoints and Tests)
Figure 1-3: Market Shares of Industry Segments of the Global In Vitro Toxicity Testing Markets, 2018 (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc.])
CHAPTER TWO: INTRODUCTION
OBJECTIVES OF THE STUDY
MARKET DEFINITION AND SCOPE
Markets Covered
RESEARCH METHODOLOGY
CHAPTER THREE: MARKET OVERVIEW
INTRODUCTION TO IN VITRO TOXICITY TESTING
The Concept of 3Rs
Table 3-1: Selected Centers of 3Rs Worldwide
The ToxCast and Tox21 Programs, USA
AXLR8 Project, Europe
DB-ALM, Europe
OECD
ICH
International Cooperation on Cosmetics Regulation (ICCR)
International Cooperation on Alternative Test Methods (ICATM)
Regulatory Landscape, USA
Regulatory Landscape, European Union (EU)
Regulatory Landscape, Japan
Regulatory Landscape, China
Regulatory Landscape, India
Table 3-2: Regulatory Systems and Legislation in India Relevant for In Vitro Toxicity Testing Market
Regulatory Landscape, South Korea
Table 3-3: Major Events That Have Shaped the Global In Vitro Toxicity Testing Markets
Table 3-4: In Vitro Toxicity Testing Methods Validated by Regulatory Agencies
INDUSTRY TRENDS
Rising Innovation Leading to In Vitro Models Closer to Human Systems
Emergence of Advanced Technology Platform Companies and Long-Term Partnership Business Models
Consolidation of CRO segment in Response to Rising Outsourcing Trends in Pharma Sector
Table 3-5: Examples of Recent M&A Deals in CRO Segment Relevant for In Vitro Toxicity Testing Markets 40
MARKET DRIVERS
Rising Focus on Alternative Models for Toxicity Testing
Increasing Demand for Early Toxicology Testing
Ban on Animal Testing in the Cosmetics Industry
Regulations and Large-Scale Initiatives by Governments
Innovation in Cell Culture Technologies
MARKET RESTRAINTS
Reluctance of Regulatory Agencies to Consider Alternative Methods
Technical Challenges to Develop In Vitro Models That Can Mimic In Vivo Complexities
Human Resource Challenges
CHAPTER FOUR: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINTS AND TESTS
INTRODUCTION
Table 4-1: Global In Vitro Toxicity Testing Market, by Toxicity Endpoints and Tests (2018-2023) ($, Million) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
ADME-TOX
Table 4-2: Types of Measurements Conducted during In Vitro ADME Screening
Solution Properties
Absorption and Transport
Metabolism
Drug-Drug Interactions (DDI)
High Throughput ADME Screening
Table 4-3: Selected Companies Active in ADME-Tox Testing and Their Activities
Table 4-4: Markets for In Vitro ADME-Tox Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
SKIN IRRITATION, CORROSION AND SENSITIZATION
Skin Irritation
Skin Corrosion
Skin Sensitization
Table 4-5: Selected Companies Offering In Vitro Skin Irritation, Corrosion and Sensitization Toxicity Testing Products and Services
Table 4-6: Markets for In Vitro Skin Irritation, Corrosion and Sensitization Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
GENOTOXICITY
Table 4-7: Regulatory Overview for In Vitro Genotoxicity Testing by US FDA and EMA
Table 4-8: Selected Companies Offering In Vitro Genotoxicity Testing Products and Services
Table 4-9: Markets for In Vitro Genotoxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CYTOTOXICITY
Table 4-10: Selected Companies Offering In Vitro Cytotoxicity Testing Products and Services
Table 4-11: Markets for In Vitro Cytotoxicity Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
OCULAR TOXICITY
Ex Vivo Tests
In Vitro tests
Table 4-12: 2D and 3D In Vitro Assays Used for Ocular Toxicity Testing
Table 4-13: Selected Companies Offering In Vitro Ocular Toxicity Testing Products and Services
Table 4-14: Markets for In Vitro Ocular Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
ORGAN TOXICITY
Hepatotoxicity
Cardiotoxicity
Nephrotoxicity
Table 4-15: Selected Companies Offering In Vitro Organ Toxicity Testing Products and Services
Table 4-16: Markets for In Vitro Organ Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
PHOTOTOXICITY
Table 4-17: Selected Companies Offering In Vitro Phototoxicity Testing Products and Services
Table 4-18: Markets for In Vitro Phototoxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
DERMAL TOXICITY
Table 4-19: Selected Companies Offering Products and Services Relevant for In Vitro Dermal Toxicity Testing
Table 4-20: Markets for In Vitro Dermal Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CARCINOGENICITY
Table 4-21: Selected Companies Offering In Vitro Carcinogenicity Testing Products and Services
Table 4-22: Markets for In Vitro Carcinogenicity Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
NEUROTOXICITY
Table 4-23: Selected Companies Offering In Vitro Neurotoxicity Testing Products and Services
Table 4-24: Markets for In Vitro Neurotoxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
OTHER TOXICITY ENDPOINTS AND TESTS
Endocrine Disruptors
Table 4-25: Laws and Activities Relevant to Endocrine Disruptors Testing Worldwide
Developmental and Reproductive Toxicity (DART)
Ecotoxicity
Table 4-26: Selected In Vitro Assays Used for Ecotoxicity Testing
Respiratory Toxicity
Table 4-27: In Vitro Models Used in Respiratory Toxicity Testing
Table 4-28: Selected Companies Offering In Vitro Ecotoxicity, Endocrine disruptors, DART and Respiratory Toxicity Testing Products and Services
Table 4-29: Global Demand for Other Toxicity Endpoints and Tests within In Vitro Toxicity Testing Markets, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHAPTER FIVE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
INTRODUCTION
Table 5-1: Global In Vitro Toxicity Testing Market, by Technology (2018-2023) ($, Million) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
CELL CULTURE TECHNOLOGIES
Primary Cells
Cell Lines
Choosing between Primary and Continuous Cells
Table 5-2: Major Differences between Primary Cells and Continuous Cell Lines
Stem Cells
Rising Popularity of 3D Cell Cultures
Table 5-3: Major differences between 2D Cell Culture and 3D Cell Culture
Table 5-4: A Comparison of Various 3D Cell Culture Technologies
Table 5-5: 3D Cell Culture Systems on the Market
Table 5-6: Selected Companies Offering Cells and Cell Culture Technologies
Recent Innovations in the Cell Culture Technology Segment
Table 5-7: Markets for Cell Culture Technologies for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
HIGH THROUGHPUT TECHNOLOGIES
Table 5-8: Selected Companies Offering High Throughput Technology Based Products and Services for In Vitro Toxicity Testing
Table 5-9: Markets for High Throughput Technologies for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CELLULAR IMAGING TECHNOLOGIES
3D Cellular Imaging
Current Developments in HCS Markets
Table 5-10: Evolving Capabilities of HCS Systems Enabling New Applications
Table 5-11: Selected Companies Offering Cellular Imaging Technologies for In Vitro Toxicity Testing
Table 5-12: Markets for Cellular Imaging Technologies for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
TOXICOGENOMICS (TGX)
Table 5-13: Selected Companies Offering Toxicogenomics Technologies for In Vitro Toxicity Testing
Table 5-14: Markets for Toxicogenomics Technologies for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHAPTER SIX: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
INTRODUCTION
Table 6-1: Global In Vitro Toxicity Testing Market, by Industry (2018-2023) ($, Million) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc.], Total)
PHARMACEUTICAL INDUSTRY
Table 6-2: Markets for In Vitro Toxicity Testing in the Pharmaceutical Industry, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
COSMETICS INDUSTRY
Table 6-3: Common In Vitro Assays for Testing Various Toxicity Endpoints of Cosmetics Products
Table 6-4: Markets for In Vitro Toxicity Testing in the Cosmetics Industry, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHEMICAL INDUSTRY
Table 6-5: Markets for In Vitro Toxicity Testing in the Chemical Industry, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
OTHERS (FOOD, MEDICAL DEVICES, ETC)
Food industry
Table 6-6: Common Toxicity Endpoints and In Vitro Assays Used for Testing Various Food Contact Materials (FCMs)
Medical Devices
Table 6-7: In Vitro Toxicity Testing Markets in Other Industry Segments, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHAPTER SEVEN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
INTRODUCTION
Table 7-1: Global In Vitro Toxicity Testing Market, by Method (2018-2023) ($, Million) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
BIOCHEMICAL ASSAYS
Gene Expression and Protein Secretion Assays
Table 7-2: Selected Companies Offering Biochemical Assays for In Vitro Toxicity Testing
Table 7-3: Markets for Biochemical Assays in In Vitro Toxicity Testing Markets, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
2D CELL-BASED ASSAYS
Non-Mammalian Cell-based Assays
Ames Tests
2D Mammalian Cell-based Assays
Sandwich Cultures and Micropatterning
Increasing Role of Stem Cell-based Assays in In Vitro Toxicity Testing
Table 7-4: Key Vendors of Commercial iPSCs for In Vitro Toxicity Testing
Resurgence of Phenotypic Cell-based Assays in Early Toxicity Testing
Table 7-5: Key Vendors of Phenotypic Cell-based Assays for Early Toxicity Testing
Insights on Cell-based Assay Procurement Practices
Impact of Regulation on Cell-based Assay Markets
Table 7-6: Cell-based Assays Validated by Regulatory Agencies for Various Toxicity Endpoints
2D Cell-based Assay Market Trends and Forecasts
Table 7-7: Markets for 2D Cell-based Assays within In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
3D CELL CULTURE ASSAYS AND EX VIVO SYSTEMS
Assays Based on Organoids
Assays Based on 3D Bioprinting
Organ-on-a-Chip Models
Table 7-8: Selected Companies Offering 3D Cell Culture Assays and Ex Vivo Systems for In Vitro Toxicity Testing
Table 7-9: Markets for 3D Cell Culture Assays and Ex Vivo Systems within In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHAPTER EIGHT: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCTS AND SERVICES
INTRODUCTION
Table 8-1: Global In Vitro Toxicity Testing Market, by Products and Services (2018-2023) ($, Million) (Assays, Services, Reagents & Labware, Total)
ASSAYS
Bacterial Toxicity Assays
Table 8-2: Selected Companies Offering Bacterial Toxicity Testing Products and Services
Cell-based ELISA and Western Blots
Table 8-3: Selected Companies Offering Cell-Based ELISAs and Western Blots for In Vitro Toxicity Testing
Enzyme Toxicity Assays
Table 8-4: Selected Companies Offering Enzyme Toxicity Assays and Related Services
Receptor Binding Assays
Table 8-5: Receptor Binding Assays Validated by Regulatory Agencies
Tissue Culture Assays
Other Assays
Table 8-6: Selected Companies Offering Tissue Culture Assay Products and Services
Table 8-7: Markets for Various Assays for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
REAGENTS AND LABWARE
Consumables for Cell Cultures
Microplates, Readers, etc
Labware, Instrumentation, and Reagents for HCS
Table 8-8: Selected Companies Offering Reagents and Labware for In Vitro Toxicity Testing
Table 8-9: Markets for Reagents and Labware for In Vitro Toxicity Testing, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
SERVICES
Table 8-10: Selected CROs Offering In Vitro Toxicology Testing Services
Table 8-11: Markets for In Vitro Toxicity Testing Services, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
CHAPTER NINE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
Table 9-1: Global In Vitro Toxicity Testing Market, by Region (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
EUROPE
Germany
Table 9-2: Selected Laws Relevant for In Vitro Toxicity Testing Markets in Germany
Table 9-3: Selected Companies Active in the Field of In Vitro Toxicity Testing in Germany
The United Kingdom (UK)
Table 9-4: Selected Companies Active in the Field of In Vitro Toxicity Testing in the UK
France
Table 9-5: Selected Companies Active in the Field of In Vitro Toxicity Testing in France
Italy
Table 9-6: Selected Companies Active in the Field of In Vitro Toxicity Testing in Italy
Spain
Table 9-7: Selected Companies Active in the Field of In Vitro Toxicity Testing in Spain
Rest of Europe (RoE)
Table 9-8: Selected Companies Active in the Field of In Vitro Toxicity Testing in Rest of Europe
Table 9-9: In Vitro Toxicity Testing Market in Europe, by Products and Services (2018-2023) ($, Million) (North America, Europe, Asia Pacific, ROW, Total)
Table 9-10: In Vitro Toxicity Testing Markets in Europe: By Toxicity Endpoints (2018-2023) ($, Million) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
Table 9-11: In Vitro Toxicity Testing Markets in Europe: By Technology (2018-2023) ($, Million) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
Table 9-12: In Vitro Toxicity Testing Markets in Europe: By Method (2018-2023) ($, Million) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
Table 9-13: In Vitro Toxicity Testing Markets in Europe: By Industry (2018-2023) ($, Million) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc.], Total)
NORTH AMERICA
USA
Table 9-14: Selected Companies Active in the Field of In Vitro Toxicity Testing in the USA
Canada
Table 9-15: Selected Companies Active in the Field of In Vitro Toxicity Testing in Canada
Table 9-16: In Vitro Toxicity Testing Markets in North America: By Products and Services (2018-2023) ($, Million) (Assays, Services, Reagents & Labware, Total)
Table 9-17: In Vitro Toxicity Testing Markets in North America: By Toxicity Endpoints (2018-2023) ($, Million) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
Table 9-18: In Vitro Toxicity Testing Markets in North America: By Technology (2018-2023) ($, Million) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
Table 9-19: In Vitro Toxicity Testing Markets in North America: By Method (2018-2023) ($, Million) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivosystems, Total)
Table 9-20: In Vitro Toxicity Testing Markets in North America: By Industry (2018-2023) ($, Million) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc], Total)
ASIA PACIFIC
Japan
Table 9-21: Selected Companies Active in the Field of In Vitro Toxicity Testing in Japan
China
Table 9-22: Selected Companies Active in the Field of In Vitro Toxicity Testing in China
India
Table 9-23: Selected Companies Active in the Field of In Vitro Toxicity Testing in India
Rest of APAC
Table 9-24: In Vitro Toxicity Testing Markets in APAC: By Products and Services (2018-2023) ($, Million) (Assays, Services, Reagents & Labware, Total)
Table 9-25: In Vitro Toxicity Testing Markets in APAC: By Toxicity Endpoints (2018-2023) ($, Million) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
Table 9-26: In Vitro Toxicity Testing Markets in APAC: By Technology (2018-2023) ($, Million) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
Table 9-27: In Vitro Toxicity Testing Markets in APAC: By Method (2018-2023) ($, Million) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
Table 9-28: In Vitro Toxicity Testing Markets in APAC: By Industry (2018-2023) ($, Million) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc], Total)
CHAPTER TEN: IN VITRO TOXICOLOGY TESTING COMPANY PROFILES
BIOIVT GROUP
CELL BIOLABS, INC.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CITOXLAB GROUP
COVANCE INC.
CREATIVE BIOARRAY
CYPROTEX PLC (CURRENTLY UNDER EVOTEC AG)
ENZO LIFE SCIENCES, INC. (SUBSIDIARY OF ENZO BIOCHEM, INC.)
EUROFINS SCIENTIFIC S.E.
GENTRONIX LIMITED
HEMOGENIX, INC.
MATTEK CORPORATION
MB RESEARCH LABORATORIES
MIMETAS B.V.
ORGANOVO HOLDINGS, INC.
THERMO FISHER SCIENTIFIC INC.
TISSUSE GMBH
XENOMETRIX AG
APPENDIX: COMPANY NAMES & ADDRESSES
COMPANY NAMES & ADDRESSES
3D Biotek, LLC
3Dynamic Systems Ltd
Absorption Systems
Abzena
Across Barriers GmbH
Admescope Ltd
Agilent Technologies
Albany Molecular Research Inc. (AMRI)
Alcyomics Ltd
AllCells, LLC
Alternative Toxicity Services
American Type Culture Collection (ATCC)
An-eX analytical services ltd
Anthem BioSciences
Applied Genetics Laboratories, Inc.
APSciences
Ascendance Biotechnology (formerly Hepregen Corporation)
AseaCyte Sdn Bhd
Asinex Ltd
Aspect Biosystems
Aurigene Discovery Technologies Limited
AvantiCell
Bio TeSys GmbH
Bioalternatives SAS
BioIVT
Bioneeds India Private Limited
biopta (Group of Reprocell Europe)
Bio-Rad Laboratories, Inc.
BioReliance Corporation
Bioscience Laboratories
BioScreen Testing Services, Inc.
BioSeek Inc.
BioStatus
BioTalentum Ltd
BioTek Instruments, Inc.
Catalent Pharma Solutions
CellSystems Biotechnologie Vertrieb GmbH
Celther Poland
Charles River Laboratories International Inc.
ChemDiv
ChemPartner
ClinWorld (P) Ltd
CN Bio Innovations Limited
Concord Biosciences LLC
Corning
Covance, Inc. (a part of Laboratory Corporation of America Holdings)
Creative Animodel
Creative Bioarray
Creative Biolabs
Crown Bioscience Inc.
Cultex Laboratories GmbH
Cyfuse Biomedical K.K
Cyprotex PLC (a subsidiary of Evotec Ag)
Cytox
Dermal Technology Laboratory Ltd
ebpi (environmental bio-detection products inc)
Empiriko Corporation
Emulate, Inc.
Enmine LLC
Envigo RMS, Inc.
Epithelix Sàrl
Evercyte GmbH
GE Healthcare
Gentronix Limited
GLR Laboratories Pvt Ltd
GVK Biosciences Private Limited
Hμrel Corporation
HCS Pharma
HD Biosciences
Helix3inc
HemoGenix, Inc.
Hutchison Medi Pharma
ImQuest BioSciences
In Vitro International (IVRO)
INDIGO Biosciences, Inc.
InSphero AG
Institute for In Vitro Sciences, Inc. (IIVS)
Intertek
Invitrocue Limited
Jai Research Foundation
Joinn Laboratories
Jubilant Biosys Limited
Kirkstall, Ltd
KIYATEC
LAUS Corp
Life Chemicals USA, Inc.
Lonza Group Ltd
L’Oréal International
Marin Biologic Laboratories
MatTek Corporation
MB Research Laboratories
Medicilon
Merck KGaA
Microbac Laboratories, Inc.
Mimetas B.V.
MR Research Laboratory
Nano3D Biosciences, Inc.
NOF America Corp
Olympus
ORGANOGENIX, Inc.
Organovo Holdings Inc.
Oroxcell SAS
OxSyBio
Pacific BioLabs
PerkinElmer
Pharmaron Beijing Co., Ltd
Promega Corporation
Puracyp, Inc.
Qgel SA
regenHu Ltd
ReproCELL Europe Ltd
RTC – Research Toxicology Centre
Sai Life Science Ltd
Sanofi Pasteur VaxDesign Campus
Sekisui Xeno Tech, LLC
SenzaGen AB
SGS SA
STEMCELL Technologies
Sundia Meditech
Syngene International Ltd
Synthecon
TCG Life Science (Chembiotek)
Thermo Fisher Scientific
TissUse GmbH
Trevigen
Vanta Bioscience Limited
Vimta Labs
Vipragen Biosciences Private Limited
Vitro Biopharma
VitroScreen S.r.L.
Viva Biotech Ltd
Vivo Bio Tech Ltd
Vivotecnia Research
WuXi AppTec
Xenometrix AG
Zyleris Pharmatech, Inc.
GLOSSARY
Table G-1: Glossary
